NCT02816112 2020-05-27
REaCT-TC2
Ottawa Hospital Research Institute
Phase 4 Completed
Clinical Trials
3 trialsNCT02173262 2017-11-06
OTT14-03
Ottawa Hospital Research Institute
Phase 4 Completed
NCT00590785 2017-08-25
Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)
National Cancer Institute (NCI)
Phase 3 Completed